ASTRONICS CORP (ATRO)

US0464331083 - Common Stock

16.77  +0.11 (+0.66%)

After market: 16.77 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ATRO. ATRO was compared to 63 industry peers in the Aerospace & Defense industry. The financial health of ATRO is average, but there are quite some concerns on its profitability. ATRO is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year ATRO has reported negative net income.
ATRO had a negative operating cash flow in the past year.
In the past 5 years ATRO reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: ATRO reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -4.17%, ATRO is doing worse than 60.32% of the companies in the same industry.
With a Return On Equity value of -10.59%, ATRO perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
ROA -4.17%
ROE -10.59%
ROIC N/A
ROA(3y)-4.73%
ROA(5y)-5.24%
ROE(3y)-11.82%
ROE(5y)-12.98%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of ATRO (17.52%) is worse than 60.32% of its industry peers.
In the last couple of years the Gross Margin of ATRO has declined.
ATRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y-4.87%

4

2. Health

2.1 Basic Checks

ATRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATRO has more shares outstanding
ATRO has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ATRO has an improved debt to assets ratio.

2.2 Solvency

ATRO has an Altman-Z score of 3.49. This indicates that ATRO is financially healthy and has little risk of bankruptcy at the moment.
ATRO has a better Altman-Z score (3.49) than 63.49% of its industry peers.
ATRO has a Debt/Equity ratio of 0.64. This is a neutral value indicating ATRO is somewhat dependend on debt financing.
ATRO's Debt to Equity ratio of 0.64 is in line compared to the rest of the industry. ATRO outperforms 41.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z 3.49
ROIC/WACCN/A
WACC9.55%

2.3 Liquidity

ATRO has a Current Ratio of 2.72. This indicates that ATRO is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ATRO (2.72) is better than 69.84% of its industry peers.
A Quick Ratio of 1.38 indicates that ATRO should not have too much problems paying its short term obligations.
ATRO has a Quick ratio (1.38) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.72
Quick Ratio 1.38

4

3. Growth

3.1 Past

ATRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.76%, which is quite impressive.
ATRO shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.85%.
Measured over the past years, ATRO shows a decrease in Revenue. The Revenue has been decreasing by -3.02% on average per year.
EPS 1Y (TTM)56.76%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q195.24%
Revenue 1Y (TTM)28.85%
Revenue growth 3Y11.1%
Revenue growth 5Y-3.02%
Revenue growth Q2Q23.45%

3.2 Future

ATRO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 110.80% yearly.
The Revenue is expected to grow by 2.56% on average over the next years.
EPS Next Y222.19%
EPS Next 2Y110.8%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.04%
Revenue Next 2Y10.5%
Revenue Next 3Y2.24%
Revenue Next 5Y2.56%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATRO. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 28.59 indicates a quite expensive valuation of ATRO.
Based on the Price/Forward Earnings ratio, ATRO is valued a bit cheaper than the industry average as 65.08% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ATRO to the average of the S&P500 Index (21.32), we can say ATRO is valued slightly more expensively.
Industry RankSector Rank
PE N/A
Fwd PE 28.59

4.2 Price Multiples

ATRO's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 57.93

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ATRO's earnings are expected to grow with 110.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y110.8%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ATRO!.
Industry RankSector Rank
Dividend Yield N/A

ASTRONICS CORP

NASDAQ:ATRO (4/30/2024, 3:20:03 PM)

After market: 16.77 0 (0%)

16.77

+0.11 (+0.66%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap971.65M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.59
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.17%
ROE -10.59%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 17.52%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.72
Quick Ratio 1.38
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)56.76%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y222.19%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)28.85%
Revenue growth 3Y11.1%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y